Literature DB >> 10841830

Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.

E E Perrone1, C Theoharis, N R Mucci, S Hayasaka, J M Taylor, K A Cooney, M A Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10841830     DOI： 10.1093/jnci/92.11.937

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

1.  Automated acquisition of stained tissue microarrays for high-throughput evaluation of molecular targets.

Authors:  Hans Vrolijk; Willem Sloos; Wilma Mesker; Patrick Franken; Riccardo Fodde; Hans Morreau; Hans Tanke
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

Review 2.  Tissue microarrays.

Authors:  Susan Henshall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

3.  ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.

Authors:  Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael S Sabel; Matthias D Hofer; Sooryanarayana Varambally; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark L Day
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

Review 4.  Cancer immunology--analysis of host and tumor factors for personalized medicine.

Authors:  Shuji Ogino; Jérôme Galon; Charles S Fuchs; Glenn Dranoff
Journal:  Nat Rev Clin Oncol       Date:  2011-08-09       Impact factor: 66.675

5.  Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

Authors:  D Gancberg; A Di Leo; G Rouas; T Järvinen; A Verhest; J Isola; M J Piccart; D Larsimont
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

6.  Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.

Authors:  S Manley; N R Mucci; A M De Marzo; M A Rubin
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 7.  The role of the pathologist as tissue refiner and data miner: the impact of functional genomics on the modern pathology laboratory and the critical roles of pathology informatics and bioinformatics.

Authors:  M J Becich
Journal:  Mol Diagn       Date:  2000-12

8.  Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.

Authors:  Dinesh S Rao; Teresa S Hyun; Priti D Kumar; Ikuko F Mizukami; Mark A Rubin; Peter C Lucas; Martin G Sanda; Theodora S Ross
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

10.  Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.

Authors:  Matthias D Hofer; Alice Fecko; Ronglai Shen; Sunita R Setlur; Kenneth G Pienta; Scott A Tomlins; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.